Summary
LSZ is chemically related to LSD active at similar dosages, with one of its isomers more potent in rats than d-LSD. LSZ sold on white blotter became commercially available in mid 2013. LSZ is one of a group of ergoloids developed by David Nichols' lab at Purdue in the early 2000s, but there are unconfirmed reports that LSZ was previously available on blotter prior to Nichols' first publication. LSZ has three stereoisomers, one (S,S) is substantially more potent than the other three.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 100-150µg | 150-300µg | 300-400µg | 400µg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|---|
| Oral | 19-60 min | 30-60 min | 3.0-5.0 hrs | 2.0-3.0 hrs | 6.0-24.0 hrs | 6.0-10.0 hrs |
Tolerance
Build-up
develops rapidly after a single use
Reset
7–14 days for baseline
Cross-tolerance
Effects
Positive
- Stimulation
- Creativity enhancement
- Mental/physical stimulation
Negative
- Nausea
- Pupil dilation
- Restlessness
- Sweating/chills
- Muscle tension
- Insomnia
- Decreased appetite
Positive
- Analysis enhancement
- Conceptual thinking
- Emotion enhancement
- Mindfulness
- Spirituality enhancement
- Unity and interconnectedness
- Wakefulness
- Euphoria
- Empathy
- Insight
Negative
- Memory suppression
- Thought disorganization
- Thought loops
- Confusion
- Depth perception distortions
- Perspective distortions
- Personal bias suppression
- Thought acceleration
- Time distortion
- Change in perception
- Ego softening
Positive
- Bodily control enhancement
- Color enhancement
- Pattern recognition enhancement
- Visual acuity enhancement
- Colour shifting
- Tracers
- Increased music appreciation
- Brightened colour
- Enhanced tactile sensation
Negative
- Drifting
- Symmetrical texture repetition
- Internal hallucination
- Autonomous entities
- Closed/Open eye visuals